Home › NDC Lookup › RxCUI directory › RxCUI 1013629

{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Ta... — RxCUI 1013629

RxNorm drug concept · Generic pack
RxCUI 1013629 Generic pack · GPCK ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1013629
Official name{24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asDrospiren-Eth estra-Levomefol Ca 3-0.02-0.451 MG (24) Oral Tablet / Levomefol Ca 0.451 MG (4) Oral Tablet 28 Day Pack
FDA products mapped3
Package NDCs mapped6
Reported Medicaid activity (SDUD)10,409 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Drospirenone / Ethinyl Estradiol / Levomefolate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's primarily a birth control pill, but it does a few things at once. The hormone combination stops ovulation to prevent pregnancy. It also includes a form of folate (a B vitamin)...
  • What is this pill actually doing — is it just birth control?
  • The first one to three packs are the most likely time to notice nausea, spotting between periods, breast tenderness, or headaches. These usually settle down on their own — don't st...
  • What side effects should I expect when I first start taking it?
📖 Read our full Drospirenone / Ethinyl Estradiol / Levomefolate guide →

🕸️ Concept Web — How {24 (drospirenone 3 MG / ethinyl estradiol 0.02... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG / levomefolate calcium 0.451 MG Oral Tablet) / 4 (levomefolate calcium 0.451 MG Oral Tablet) } Pack RxCUI 1013629

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Drospirenone 11636
    • Ethinyl estradiol 4124
    • Levomefolate 1592257
    • Drospirenone / ethinyl estradiol / levomefolate 1013625
    • Levomefolate calcium 1028454
  2. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Drospirenone / ethinyl estradiol / levomefolate Oral Tablet 1013624
    • Levomefolate Oral Tablet 1013627
    • Drospirenone / ethinyl estradiol / levomefolate calcium Oral Tablet 2646163
    • Levomefolate calcium Oral Tablet 2648456
    • Drospirenone / ethinyl estradiol / levomefolate Oral Product 1861727
    • Drospirenone / ethinyl estradiol / levomefolate Pill 1861726
    • Levomefolate Oral Product 1861728
    • Levomefolate Pill 1861729
    • +7 more in this family
  3. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 20 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 1013629 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00781-4075-15 3 BLISTER PACK in 1 CARTON (0781-4075-15) / 1 KIT in 1 BLIS... Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium Sandoz Inc 2016-10-12
50419-0407-00 90 BLISTER PACK in 1 PACKAGE (50419-407-00) / 1 KIT in 1 BL... Beyaz Bayer HealthCare Pharmaceuticals Inc. 2010-10-07
50419-0407-03 3 BLISTER PACK in 1 PACKAGE (50419-407-03) / 1 KIT in 1 BLI... Beyaz Bayer HealthCare Pharmaceuticals Inc. 2010-10-07
50419-0407-70 90 BLISTER PACK in 1 PACKAGE (50419-407-70) / 1 KIT in 1 BL... Beyaz Bayer HealthCare Pharmaceuticals Inc. 2010-10-07
50419-0407-75 12 PACKAGE in 1 CARTON (50419-407-75) / 5 BLISTER PACK in 1... Beyaz Bayer HealthCare Pharmaceuticals Inc. 2010-10-07
68180-0894-73 3 POUCH in 1 CARTON (68180-894-73) / 1 BLISTER PACK in 1 PO... drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium Lupin Pharmaceuticals, Inc. 2018-08-22
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (4) · Lupin Pharmaceuticals, Inc. (1) · Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.